FXN and Friedreich ataxia: Given successful microglial differentiation, we next examined FXN protein levels, finding decreased FXN in FRDA patients, and confirmed the efficacy of our gene editing strategy which restored FXN protein levels in gene-edited iMGs (Fig. 1d).